Kapellas N, Alkhalil S, Hero T, Senkal M
Hernia Specialty Center, Department of General and Visceral Surgery, Marien Hospital Witten, 58452, Witten, Germany.
Department of Radiation Oncology, Evangelisches Krankenhaus Witten, Witten, Germany.
Hernia. 2025 Mar 27;29(1):126. doi: 10.1007/s10029-025-03318-7.
Postoperative lymphatic leakage (PLL) is a rare and poorly understood complication following laparoscopic inguinal hernia repair (LIHR). While seroma is a well-documented postoperative finding, the potential for lymphatic leakage and subsequent lymphatic fistula is frequently overlooked and often misclassified. This report presents a unique case of postoperative lymphocele following Totally Extraperitoneal (TEP) inguinal hernia repair and discusses diagnostic considerations, management strategies, and implications for surgical practice.
We report the case of a 56-year-old male who developed a large, symptomatic inguinal lymphocele after undergoing TEP LIHR. Diagnosis was confirmed via magnetic resonance imaging (MRI) and analysis of the drained fluid. Management involved surgical drainage followed by low-dose radiotherapy. A narrative literature review was also performed to identify existing evidence on PLL following LIHR.
The patient developed a significant septated fluid collection (115 × 60 × 50 mm) compressing the bladder, consistent with a lymphocele. Drain output peaked at 350 mL/day. Fractionated low-dose radiotherapy (0.5 Gy × 10 sessions) led to a marked reduction in lymphatic output to <10 mL/day, permitting safe drain removal. At two-month follow-up, the patient remained asymptomatic. A narrative literature search revealed no previously reported cases of PLL following LIHR.
To our knowledge, this is the first reported case of lymphocele and lymphatic fistula formation following TEP LIHR. This case highlights the need to recognize lymphatic leakage as a distinct complication. Low-dose radiotherapy appears to be an effective, minimally invasive treatment. Standardized terminology and further research are essential to improve diagnosis and management.
术后淋巴漏(PLL)是腹腔镜腹股沟疝修补术(LIHR)后一种罕见且了解甚少的并发症。虽然血清肿是一种有充分文献记载的术后表现,但淋巴漏及随后形成淋巴瘘的可能性常被忽视且常被误诊。本报告介绍了一例完全腹膜外(TEP)腹股沟疝修补术后发生的独特的术后淋巴管瘤病例,并讨论了诊断要点、治疗策略以及对手术实践的启示。
我们报告了一例56岁男性患者,在接受TEP LIHR后出现了一个大的、有症状的腹股沟淋巴管瘤。通过磁共振成像(MRI)和对引流液的分析确诊。治疗包括手术引流,随后进行低剂量放疗。还进行了叙述性文献综述,以确定关于LIHR后PLL的现有证据。
患者出现了一个巨大的分隔性液体积聚(115×60×50mm),压迫膀胱,符合淋巴管瘤表现。引流量峰值为每天350mL。分次低剂量放疗(0.5Gy×10次)使淋巴引流量显著减少至每天<10mL,从而可以安全拔除引流管。在两个月的随访中,患者仍无症状。叙述性文献检索未发现此前有LIHR后PLL的报道病例。
据我们所知,这是首例TEP LIHR后发生淋巴管瘤和淋巴瘘形成的报道病例。该病例强调了将淋巴漏视为一种独特并发症的必要性。低剂量放疗似乎是一种有效的微创治疗方法。标准化术语和进一步研究对于改善诊断和治疗至关重要。